Microemulsion dosage forms of valsartan and methods of making the same

Details for Australian Patent Application No. 2007333355 (hide)

Owner Novartis AG

Inventors Kennedy, John Joseph; Li, Ping; Royce, Alan Edward; Wagner, Robert Frank; Joshi, Yatindra

Agent Davies Collison Cave

Pub. Number AU-B-2007333355

PCT Pub. Number WO2008/073731

Priority 60/868,604 05.12.06 US

Filing date 3 December 2007

Wipo publication date 19 June 2008

Acceptance publication date 20 October 2011

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/073731 Priority application(s): WO2008/073731

20 October 2011 Application Accepted

  Published as AU-B-2007333355

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333368-Long term disease modification using immunostimulatory oligonucleotides

2007333352-Illumination source comprising light emitting diodes for stained biological samples